2.700EURMkt Cap: —P/E: 40.914d ago
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical…
Industry Peers
Healthcare$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$375.50BUSDP/E 122.7
$341.92BUSDP/E 24.5
$348.81BUSDP/E 25.0
$279.13BUSDP/E 22.3
$274.07BUSDP/E 23.6
$240.45BUSDP/E 24.5
$231.49BUSDP/E 24.5
$238.75BUSDP/E 27.4
$226.85BUSDP/E 33.1
$190.75BUSDP/E 11.3
$198.81BUSDP/E 36.9
$183.02BUSD
$160.96BUSDP/E 37.2
$151.78BUSDP/E 38.6
$142.49BUSDP/E 45.6
$139.84BUSDP/E 32.2
$138.11BUSDP/E 14.9
Key Statistics
Company
Market Cap—
Enterprise Value355.06M $
Revenue (TTM)367.10M $
Gross Profit218.17M $
Net Income (TTM)7.54M $
Revenue/Share4.497 USD
Last Price2.700 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.5K
CountryGB
SectorHealthcare
Industry—
ISINES0165359029
Valuation
P/E (Trailing)40.91
P/E (Forward)—
PEG—
EV/EBITDA13.55
EV/Revenue0.97
P/S—
P/B1.01
EPS (TTM)0.07
EPS (Forward)—
52W Range
—
52W High2.700 EUR
52W Low2.700 EUR
Profitability
Gross Margin59.43%
Oper. Margin1.82%
EBITDA Margin7.14%
Profit Margin2.05%
ROE3.14%
ROA1.43%
Growth
Revenue Growth1.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt113.55M $
Net Debt/EBITDA4.33
Balance Sheet
Debt/Equity53.50
Current Ratio1.51
Quick Ratio0.80
Book Value/Sh2.679 EUR
Cash/Share0.1860 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.05:1
Split DateSep 22, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float21.47M
Insiders78.46%
Institutions6.82%
Technical
SMA 502.449 (+10.3%)
SMA 2002.452 (+10.1%)
Beta0.95
S&P 52W Chg20.80%
Avg Vol (30d)1
Avg Vol (10d)14
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—